SOTTILI, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 1.627
EU - Europa 788
AS - Asia 211
Totale 2.626
Nazione #
US - Stati Uniti d'America 1.621
PL - Polonia 270
IE - Irlanda 137
SE - Svezia 136
IT - Italia 117
HK - Hong Kong 81
CN - Cina 71
UA - Ucraina 28
FI - Finlandia 25
JO - Giordania 20
DE - Germania 19
SG - Singapore 16
GB - Regno Unito 15
BE - Belgio 9
ES - Italia 7
KR - Corea 7
CA - Canada 6
FR - Francia 6
IN - India 5
RU - Federazione Russa 5
AT - Austria 4
CH - Svizzera 4
TR - Turchia 4
VN - Vietnam 4
NL - Olanda 3
JP - Giappone 2
BY - Bielorussia 1
CZ - Repubblica Ceca 1
PH - Filippine 1
RO - Romania 1
Totale 2.626
Città #
Warsaw 270
Fairfield 229
Chandler 220
Ashburn 146
Dublin 137
Seattle 124
Woodbridge 100
Cambridge 87
Houston 82
Ann Arbor 76
Wilmington 74
Hong Kong 52
Altamura 47
Lawrence 47
Princeton 43
Beijing 40
Jacksonville 37
Dearborn 35
Boston 25
Shanghai 19
Buffalo 17
San Diego 15
Florence 13
Medford 13
Boardman 11
Falls Church 11
Singapore 10
Brussels 9
New York 8
Norwalk 8
A Coruña 7
Seoul 7
Andover 5
Redwood City 5
Toronto 5
Bern 4
Cagliari 4
Dong Ket 4
Hillsboro 4
Izmir 4
Kent 4
Moscow 4
Pistoia 4
Pune 4
Auburn Hills 3
Nanjing 3
Pisa 3
West Jordan 3
Castelliri 2
Frankfurt Am Main 2
Kunming 2
London 2
Phoenix 2
Romainville 2
Rome 2
Venice 2
Verona 2
Acqui Terme 1
Bethesda 1
Bracknell 1
Cabanatuan City 1
Changsha 1
Chongqing 1
Falkenstein 1
Fuzhou 1
Garden City 1
Grafing 1
Guangzhou 1
Hebei 1
Kilburn 1
Laurel 1
Los Angeles 1
Lucca 1
Milan 1
Minsk 1
Montréal 1
Nagold 1
Pioltello 1
Prague 1
Prato 1
Redmond 1
Rizziconi 1
Selargius 1
Serina 1
Stevenage 1
Thiene 1
Timisoara 1
Treviso 1
Vienna 1
Zhengzhou 1
Totale 2.133
Nome #
CXCL10 e rigetto del trapianto: studio degli analoghi della vitamina Dcome potenziali nuovi farmaci immunomodulatori 210
The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathies. 206
Immunosuppression in cardiac graft rejection: a human in vitro model to study the potential use of new immunomodulatory drugs. 120
A PPAR gamma agonist protects against oral mucositis induced by irradiation in a murine model 115
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO) 111
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 105
Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. 103
A PPAR-gamma agonist protects from radiation-induced intestinal toxicity 98
Radiotherapy in the age of cancer immunology: Current concepts and future developments 96
Soft tissue sarcomas: new opportunity of treatment with PARP inhibitors? 93
Predictive Role of Pretransplant Serum CXCL10 for Cardiac Acute Rejection 90
Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells. 88
Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes. 86
A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model 84
Enhancement of Soft Tissue Sarcoma Cell Radiosensitivity by Poly(ADP-ribose) Polymerase-1 Inhibitors 82
Cancer stem cells: biology and potential therapeutic applications 79
CXCL10 release in cardiopulmonary bypass: An in vivo and in vitro study 73
Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. 70
Rosiglitazone(RGZ) Attenuates Pulmonary Fibrosis and Radiation-induced Intestinal Damage 69
Methimazole inhibits CXC chemokine ligand 10 secretion in human Thyrocites. 65
Immunomodulatory effects of BXL-01-0029, a less hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells. 64
Biomarkers in wound drainage fluids of head and neck squamous cell carcinoma patients receiving neck dissection: A pilot study 59
Magnetic resonance imaging of stem cell application in oncology 56
Immunomodulatory effects of BXL-01-0029, a non hypercalcemic vitamin D analogue, in human cardiomyocytes and T cells. 53
Inhibition of poly(ADP-ribose) polymerase-1 radio-sensitizes human soft tissue sarcoma cells 47
Stimulated expression of CXCL12 in adrenocortical carcinoma by the ppargamma ligand rosiglitazone impairs cancer progression 45
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 43
Protective Effect of Leuprorelin on Radiation-induced Intestinal Toxicity 42
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 41
Protective effect of leuprorelin on radiation-induced intestinal toxicity 37
Magnetic resonance imaging in stem cell applications 37
Insulin-like effect of the phosphodiesterase type 5 inhibitor tadalafil onto male human skeletal muscle cells. 34
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 33
RADIOSENSITIZING EFFECT OF ROSIGLITAZONE IN HEAD-NECK CARCINOMA AND PROTECTION IN RADIATION-INDUCED MUCOSITIS 31
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 9
Totale 2.674
Categoria #
all - tutte 8.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.311


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019150 0 0 0 0 0 0 0 0 0 0 80 70
2019/2020624 42 37 7 51 75 91 83 69 61 56 43 9
2020/2021299 29 26 23 25 12 38 11 25 28 38 24 20
2021/2022241 12 20 12 19 9 7 11 24 11 11 35 70
2022/2023761 74 169 43 48 59 135 84 48 71 2 21 7
2023/2024262 9 26 35 8 23 36 19 78 3 13 12 0
Totale 2.674